Startups

Pipe17: AI-Based Order Operations Solutions Company Raises $15.5 Million (Series A)

By Amit Chowdhry ● Jan 14, 2025

Pipe17, a leading provider of AI-based composable order operations, announced a $15.5 million funding round, highlighting the company's rapid growth and strategic vision to transform commerce operations. And the company recently hired its first Chief Operating Officer, Kelly Goetsch, a recognized industry pioneer who joined Pipe17 from commercetools, where he helped scale the company to over $100 million in annual recurring revenue (ARR).

Float Financial: C$70 Million (Series B) Raised For Building Business Solutions

By Amit Chowdhry ● Jan 13, 2025

Float Financial, a business finance platform for Canadian businesses, has signed a C$70 million Series B financing round, bringing its total funds raised in the last year to $120 million. The funding round was led by Growth Equity at Goldman Sachs Alternatives, with participation from OMERS Ventures, FJ Labs, Teralys, and existing investor Garage Capital.

hc1: $6.25 Million Raised To Transform Lab Data Into Actionable Intelligence

By Amit Chowdhry ● Jan 13, 2025

hc1, a leader in transforming lab data into actionable intelligence that improves patient health outcomes while boosting the bottom line, announced it raised $6.25 million in new financing after a successful acquisition in October 2024 of Accumen. Existing investor Health Cloud Capital led the investment with participation from health tech investment firm A1 Health Ventures. And Arsenal Capital Partners joined the investor base in the combined platform via its ownership stake in Accumen.

ThreatMark: $23 Million Raised To Fight Online Fraud

By Amit Chowdhry ● Jan 13, 2025

ThreatMark, a leading innovator in behavior-based fraud prevention, announced it has closed a $23 million funding round. The funding round includes $15 million from Octopus Ventures and Riverside Acceleration Capital (RAC), a US-based growth capital partner to B2B software companies, and an $8 million convertible note from Springtide Ventures Fund.

Raspberry AI: Fashion-Focused GenAI Company Raises $24 Million (Series A)

By Amit Chowdhry ● Jan 13, 2025

Raspberry AI, a leading generative AI platform for fashion creatives, announced it secured $24 million in Series A funding led by Andreessen Horowitz (a16z). Existing investors Greycroft, Correlation Ventures, and MVP Ventures participated in the round, along with notable angel investors such as Gokul Rajaram and Ken Pilot.

BBT.live: Secure Connectivity Company Raises $11.5 Million (Seed)

By Amit Chowdhry ● Jan 13, 2025

BBT.live, an innovator in secure connectivity over public infrastructure, announced the expansion of its seed funding round to $11.5 million, driven by an additional $2 million investment. Accel Solutions Group led the funding round.

Kerna Labs: Seed Funding Raised To Develop Novel RNA-Based Medicines

By Amit Chowdhry ● Jan 13, 2025

Kerna Laboratories - a San Francisco-based AI biotech startup - announced it emerged from stealth with the launch of an AI platform for developing novel RNA-based medicines. Kerna Labs has recently closed an oversubscribed seed funding round, with investors including Gradient, Humba Ventures, Tau Ventures, Pioneer Fund, Focalpoint Partners, and prominent angels including Patrick Hsu (Arc Institute) and Jacob Kimmel (NewLimit).

First Ascent Biomedical: $6 Million Raised For Personalized Cancer Treatments

By Amit Chowdhry ● Jan 13, 2025

First Ascent Biomedical, a pioneer in personalized cancer treatment, announced a $6 million investment from Vidal Duart Enterprises, with an additional co-investment from Techstars. And the funding round will accelerate First Ascent Biomedical’s mission to transform medical oncology with highly individualized, prospective treatment planning technologies that improve patient survival.

Fermata: $10 Million (Series A) Raised For Computer Vision Agriculture Solutions

By Amit Chowdhry ● Jan 13, 2025

Fermata, a data science company specializing in computer vision agriculture solutions, announced it closed $10 million in a Series A funding round backed by Raw Ventures. This funding will support the company's vision of developing a centralized digital brain for the horticulture industry, enabling autonomous management of crops through advanced data analysis and creating a system that continuously learns from available data.

Caidya: Clinical Research Organization Raises $165 Million

By Amit Chowdhry ● Jan 13, 2025

Caidya, a leading global mid-sized clinical research organization (CRO), announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building transformational companies.

Windward Bio: Drug Development Company Raises $200 Million (Series A)

By Amit Chowdhry ● Jan 13, 2025

Novo Holdings, a leading life science investor, announced that it has invested in a $200 million Series A launch financing for Windward Bio. This oversubscribed Series A launch financing was co-led by OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and joined by SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners.

RAAPID: Series A Funding Raised From Microsoft’s M12

By Amit Chowdhry ● Jan 13, 2025

Healthcare AI company RAAPID announced a significant Series A investment from M12, which is Microsoft's venture fund. And this strategic funding positions RAAPID to expand its groundbreaking Neuro-symbolic AI platform that reshapes healthcare risk adjustment.

Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders

By Amit Chowdhry ● Jan 13, 2025

Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-class monoclonal antibody targeting CD38, for diseases of high unmet medical needs. The funding was led by investors Abingworth, Bain Capital Life Sciences, and Venrock Healthcare Capital Partners, with participation from Boyu Capital, Lilly Asia Ventures, Braidwell LP, and 3H Health Investment.

nsave: $18 Million (Series A) Raised For Launching Investment Platform

By Amit Chowdhry ● Jan 13, 2025

nsave, a provider of compliant accounts abroad to people from countries with high inflation, announced launching an investment product, enabling people at risk of financial exclusion to protect and grow their wealth. The company also confirmed an $18 million Series A funding led by TQ Ventures with participation from Sequoia Capital, Y Combinator, ACE Ventures, and Proton Foundation to drive their growth.

RhyGaze: $86 Million (Series A) Raised To Develop Gene Therapies For Retinal Diseases

By Amit Chowdhry ● Jan 13, 2025

RhyGaze, a biotechnology company based in Basel, Switzerland, and Philadelphia, PA, announced that it has raised a Series A funding round of $86 million. The funding round was led by GV (Google Ventures), alongside Arch Venture Partners, F-Prime Capital, and founding investors BioGeneration Ventures and Novartis Venture Fund, who contributed $11 million to an earlier seed round.

Kardigan: $300 Million Raised For Modernizing Cardiovascular Drug Development

By Amit Chowdhry ● Jan 13, 2025

Kardigan - a heart health company modernizing cardiovascular drug development - announced it launched with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases closer to the cures they deserve. The company also recently closed a $300 million Series A financing led by Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage.

Andreessen Horowitz Partnering With Lilly On $500 Million Biotech Ecosystem Venture Fund

By Amit Chowdhry ● Jan 13, 2025

Andreessen Horowitz (a16z) Bio + Health announced a newly formed and first-of-its-kind venture capital fund to fuel broader innovation in human health in partnership with Eli Lilly and Company (Lilly). The Biotech Ecosystem Venture Fund aims to drive transformative progress in healthcare by investing in therapeutic platforms and technology companies that can bring new medicines and disease treatments to improve patients’ lives.

Normunity: $75 Million (Series B) Raised For Broadening Pipeline Of Novel Anti-Cancer Therapies

By Amit Chowdhry ● Jan 13, 2025

Normunity, a biotechnology company creating novel anti-cancer therapies, announced today that it closed a Series B funding round of $75 million. The funding was co-led by Samsara BioCapital and Enavate Sciences, alongside other new investors Regeneron Ventures, Pfizer Ventures and YK Bioventures, as well as existing investors Canaan Partners, Sanofi Ventures, Taiho Ventures, Osage Venture Partners, HongShan Capital Group, and Connecticut Innovations. And the Board of Directors will be expanded to include David Parry, PhD (Samsara), Sara Nayeem, MD (Enavate), and Marie-Clare Peakman, MD (Pfizer Ventures).

Tidal Cyber Buying Zero-Shot Security

By Amit Chowdhry ● Jan 13, 2025

Tidal Cyber, the Threat-Informed Defense company, announced the acquisition of Zero-Shot Security, the creator of an innovative artificial intelligence (AI) solution that simplifies and speeds the processing and analysis of threat intelligence.

Holly: AI-Based Government Hiring Platform Raises $2.2 Million

By Amit Chowdhry ● Jan 13, 2025

Holly, an AI-based platform modernizing government hiring, announced the closing of its $2.2 million oversubscribed pre-seed round, led by J2 Ventures with participation from Roble Ventures, Gaingels, and notable angel investors. And the funding will support Holly's platform as it works to solve the million-job government workforce vacancy crisis.

Tune Therapeutics: Over $175 Million (Series B) Raised For Advancing Field-Leading Epigenome Editing Programs

By Amit Chowdhry ● Jan 13, 2025

Leading epigenome editing company Tune Therapeutics announced the completion of over $175 million in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures, and Hevolution Foundation.

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing Clinical Development Of Precision Cell Therapies

By Amit Chowdhry ● Jan 12, 2025

A2 Biotherapeutics - a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to target tumor cells and protect normal cells selectively - announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital.

Valspring Capital: Fund I Closed Above Target At $255 Million

By Amit Chowdhry ● Jan 12, 2025

Valspring Capital, a healthcare-focused growth equity firm, announced the closing of its debut fund, Valspring Capital Fund I, above its target at $255 million. Launched in 2022 by a team spun off from Bain Capital Ventures to pursue healthcare investments with the firm’s support, the Valspring team will seek to invest primarily in growth-stage companies in the healthcare industry, focusing on the information technology, technology-enabled services, and services sectors within North America.

Phase Four: In-Space Propulsion Company Raises Series C

By Amit Chowdhry ● Jan 12, 2025

Phase Four, a leader in advanced in-space propulsion design and manufacturing, announced the first close of its Series C funding round, securing nearly 60% of the target raise with strong participation from new and existing investors. And the round is led by Artemis Group Capital, the Oklahoma-based investment firm helmed by former NASA Administrator Jim Bridenstine, emphasizing the growing confidence in Phase Four's innovative propulsion solutions.

RLTYco: $20 Million (Series A) Raised For Giving Agents Same-Day Commission Advances And Other Benefits

By Amit Chowdhry ● Jan 12, 2025

RLTYco, a New York-based full-service provider of comprehensive resources for real estate professionals, announced the closing of a $20 million Series A funding round led by Altriarch. The funding round also included participation from existing investors, including Andrew Dodge, entrepreneur and angel investor, Christopher Schmidt, Executive Vice President at Related Companies, and SERHANT. Ventures (SERHANT.’s education division that develops, creates, and produces resources and solutions for agents in today’s new marketplace). Ryan Serhant, CEO and founder of SERHANT., is a partner, advisor and ambassador via SERHANT. Ventures.

Grand Games: $30 Million (Series A) Raised To Accelerate Growth

By Amit Chowdhry ● Jan 12, 2025

Grand Games, a gaming studio behind the widely loved Magic Sort mobile game, announced it has raised a $30 million Series A round, marking its arrival as the latest up-and-coming studio to emerge from Istanbul, the gaming powerhouse that brought forth Dream Games and Peak Games. Balderton Capital led the round with participation from existing investors Bek Ventures (formerly known as Earlybird Digital East), Laton Ventures, and angel investor Mert Gür.

Oddball Raises Growth Investment From Falfurrias Management

By Amit Chowdhry ● Jan 12, 2025

Private equity firm Falfurrias Management Partners announced its growth investment in Oddball. This leading digital services agency transforms and modernizes how government organizations interact with their constituents.

Prudentia Sciences: AI-Based Life Sciences Marketplace Company Raises $7 Million

By Amit Chowdhry ● Jan 12, 2025

Prudentia Sciences, an AI-based technology platform for life sciences announced its public launch, supported by $7 million in funding. This funding round was led by GV, with participation from Iaso Ventures and Virtue.

Tenvie Therapeutics Raises $200 Million For Delivering Small Molecule Therapies

By Amit Chowdhry ● Jan 12, 2025

Advanced Ionics: Green Hydrogen Electrolyzer Company Raises $6.7 Million

By Amit Chowdhry ● Jan 12, 2025

Advanced Ionics, a developer of a new class of green hydrogen electrolyzers aimed at accelerating decarbonization, announced that it raised an additional $6.7 million in funding from strategic investors JERA, Lummus Venture Capital, the Argosy Foundation, and existing investors Clean Energy Venture Group and bp Ventures.